Future Prospects of Global Laboratory Proficiency Testing Market

Image
Laboratory Proficiency Testing Market  The global Laboratory Proficiency Testing Market is estimated to be valued at US$ 1.29 billion in 2023 and is expected to exhibit a CAGR of 7.3% over the forecast period 2023 - 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Laboratory proficiency testing involves evaluating the performance of laboratories for a given scope of testing through inter-laboratory comparisons. It helps assess the quality and competence of laboratories by determining reproducibility and accuracy of test results. Proficiency testing products are used by laboratories to determine method validity and accuracy, and improve testing processes. Market Key Trends: One of the major trends in the laboratory proficiency testing market is the growing number of accredited medical laboratories. Accreditation assures compliance with ISO 15189 and ISO/IEC 17025 standards, which require participation in proficiency testing programs. Acc...

Artificial Pancreas Device System Market Analysis and Key trends

Insulin administration might be difficult for type 1 diabetes (T1D) patients on a daily basis. Insulin pumps, pens, and jet injectors have made diabetes management easier by eliminating the need for uncomfortable insulin delivery devices like needles and syringes. Furthermore, organisations like the Juvenile Diabetes Research Foundation (JDRF) have partnered with industry leaders like Medtronic, Inc., Johnson & Johnson, and Tandem Diabetes Care, Inc. to develop breakthrough insulin and glucose monitoring systems/devices.

An insulin pump, sensor, transmitter, and receiver are all part of the artificial pancreas device system (APDS). Medtronic, Inc.'s MiniMed 530G was the first artificial pancreas device system (APDS) to be approved by the US Food and Drug Administration.

An insulin pump coupled to a continuous glucose monitor is referred to as an artificial pancreas. The monitor is controlled by sophisticated software algorithms through a receiver. It is used to aid in the regulation of blood sugar levels in persons with type 1 diabetes. The only enzyme-based hormone insulin that is now available is delivered by current technologies. Because the body normally produces and excretes insulin, the use of an artificial pancreas can assist diabetics reduce their insulin requirements by reducing the amount of the hormone generated and expelled. In most cases, they are less expensive than manual methods.

 

Artificial Pancreas Device System Market Key Trends

For the development of innovative artificial pancreas device systems Market, key market players are focused on strategic alliances and collaborations. Such collaborations among key companies may result in the creation of novel devices, propelling the artificial pancreas device system (APDS) market forward over the forecast period. For example, Diabeloop SA and ViCentra signed a distribution deal in April 2019 to make the DBLG1 artificial pancreas system commercially available in several European countries. Medtronic Plc. and DreaMed Diabetes, an Israeli firm, signed a deal in 2015 to incorporate DreaMed's patented artificial pancreas technology into Medtronic's insulin pumps. DreaMed got secret royalties for Medtronic devices that use the flagship GlucoSitter automated insulin administration system, according to the deal.


Artificial Pancreas Device System Market
Artificial Pancreas Device System


 

Comments

Popular posts from this blog

Future Prospects of Global Laboratory Proficiency Testing Market

Survival Suits Market Size, Share, Outlook, and Opportunity Analysis, 2023-2030

Global Ophthalmoscopes Market Overview and Impact of Coronavirus (Covid-19) Pandemic